Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

514.20INR
28 Aug 2014
Price Change (% chg)

Rs0.85 (+0.17%)
Prev Close
Rs513.35
Open
Rs513.30
Day's High
Rs516.00
Day's Low
Rs506.50
Volume
2,615,834
Avg. Vol
1,561,898
52-wk High
Rs517.40
52-wk Low
Rs366.50

CIPL.NS

Chart for CIPL.NS

About

Cipla Limited is a pharmaceutical company. During the fiscal year ended March 31, 2012 (fiscal 2012), it introduced a number of new drugs and formulations, such as Adgain (vital nutritional supplement for hair loss); Capnea (caffeine citrate injection and oral solution) for apnoea of prematurity in infants; Caspogin (caspofungin... (more)

Overall

Beta: 0.51
Market Cap (Mil.): Rs412,179.69
Shares Outstanding (Mil.): 802.92
Dividend: 2.00
Yield (%): 0.39

Financials

  CIPL.NS Industry Sector
P/E (TTM): 29.70 32.39 33.40
EPS (TTM): 17.28 -- --
ROI: -- 17.97 17.27
ROE: -- 18.61 18.02
Search Stocks

Cipla gains after April-June margins expand sequentially

Reuters Market Eye - Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.

18 Aug 2014

Indian shares hit record high on Modi hopes, wholesale inflation

* BSE index gains 1.1 pct; NSE ends 1.06 pct higher * Tata Motors' DVR shares up on potential index inclusion report * Cipla gains after April-June margins expand sequentially By Abhishek Vishnoi MUMBAI, Aug 18 - Indian shares rose over 1 percent on Monday to a record high as blue-chips such as ICICI Bank surged after Prime Minister Narendra Modi vowed to fire up the bureaucracy to deliver results, while easing wholesale inflation also helped. The broader NSE inde

18 Aug 2014

MARKET EYE -India's Cipla gains after April-June margins expand sequentially

* Shares in drugmaker Cipla gain 1.4 percent after April-June operating margins beat some estimates. * Margins expand sequentially by nearly 4 percentage points to 20 percent. * Investors say management maintained revenue guidance of mid-teens growth and 20 percent margins in FY15 in a conference call. * Strong growth in India and better product mix will further aid margins, fund managers add. (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

18 Aug 2014

Cipla Q1 net profit lags estimates as higher costs hurt

MUMBAI - Cipla Ltd, India's fourth-largest drugmaker by sales, on Thursday reported first-quarter profit that was much lower than expectations due to higher employee costs and other expenses.

14 Aug 2014

India's Cipla Q1 net profit lags estimates as higher costs hurt

MUMBAI, Aug 14 - Cipla Ltd, India's fourth-largest drugmaker by sales, on Thursday reported first-quarter profit that was much lower than expectations due to higher employee costs and other expenses.

14 Aug 2014

Cipla Medpro says awarded South Africa drug tender

JOHANNESBURG, Aug 7 - South Africa has awarded Cipla Medpro a 280 million rand($26 million) share of a government tender to supply therapeutic drugs from Aug. 1, the company said on Thursday.

07 Aug 2014

UPDATE 1-S.African govt awards $33 mln respiratory contract to Cipla

CAPE TOWN, June 26 - South Africa has awarded Cipla Medpro a 345 million rand ($32.6 million) share in the national respiratory tender as Africa's most advanced economy seeks to cut high asthma mortality rates, the company said on Thursday.

26 Jun 2014

S.African govt awards $33 mln respiratory contract to Cipla

CAPE TOWN, June 26 - South Africa has awarded Cipla Medpro a 345 million rand ($32.6 million) share in the national respiratory tender as Africa's most advanced economy seeks to cut high asthma mortality rates, the company said on Thursday.

26 Jun 2014

UPDATE 1-Indian shares fall over 1 pct on Iraq conflict; Fed on watch

* BSE index falls 1.1 pct; NSE index down 0.96 pct * Cipla touches 8-1/2 month high on stake-sale talk * Reliance slumps post annual shareholder meeting (Adds more stocks, and updates price action) By Abhishek Vishnoi MUMBAI, June 18 - Indian shares slipped more than 1 percent on Wednesday, falling for three out of four sessions as blue-chips including oil refiners slumped on concerns about the impact of higher oil prices on inflation and the government's finances.

18 Jun 2014

MARKET EYE -India's Cipla touches 8-1/2 month high on stake-sale talk

* India's Cipla Ltd shares rose as much as 7.3 percent to 443.25 rupees, their highest since Oct. 4, on speculation that the company's founders are in talks to sell stake to a global pharmaceutical company, multiple dealers say. * A spokeswoman for the generic drugmaker termed the rumour as baseless. (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

18 Jun 2014

Earnings vs. Estimates

Search Stocks